Slide background

OUR VIEW OF THE BIOSIMILARS WORLD

Quality, cost and  capacity

Delivering biosimilars of the highest quality, at an affordable price and in sufficient quantity is critical to success in both developed and Rest of World (RoW) markets.

NeuClone’s Right from the Start® framework allows it to produce biosimilars of high quality while also reducing manufacturing costs downstream. The Serum Institute is able to complement this by providing access to large scale manufacturing at the lowest possible cost, allowing both companies to deliver the highest quality drugs affordably.

Contact Us

Not readable? Change text.